Walter Public Investments Inc. Sells 2,900 Shares of McKesson Corporation $MCK

Walter Public Investments Inc. decreased its position in McKesson Corporation (NYSE:MCK) by 25.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,633 shares of the company’s stock after selling 2,900 shares during the period. McKesson accounts for about 1.8% of Walter Public Investments Inc.’s investment portfolio, making the stock its 24th biggest position. Walter Public Investments Inc.’s holdings in McKesson were worth $7,371,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. DSG Capital Advisors LLC lifted its stake in McKesson by 20.0% in the third quarter. DSG Capital Advisors LLC now owns 4,134 shares of the company’s stock worth $3,530,000 after acquiring an additional 690 shares during the period. Northbridge Financial Group LLC grew its holdings in McKesson by 2.1% during the 3rd quarter. Northbridge Financial Group LLC now owns 766 shares of the company’s stock worth $706,000 after acquiring an additional 16 shares in the last quarter. AMG National Trust Bank grew its holdings in McKesson by 2.0% during the 3rd quarter. AMG National Trust Bank now owns 3,596 shares of the company’s stock worth $3,071,000 after acquiring an additional 69 shares in the last quarter. Keybank National Association OH increased its position in McKesson by 4.5% during the 3rd quarter. Keybank National Association OH now owns 4,460 shares of the company’s stock valued at $3,808,000 after purchasing an additional 192 shares during the period. Finally, Cornerstone Wealth Management LLC purchased a new position in McKesson during the 3rd quarter valued at about $256,000. Institutional investors own 85.07% of the company’s stock.

McKesson News Summary

These are some of the MCK news items that stood out recently:

• Positive Sentiment: Coverage links McKesson’s new highs to pharmaceutical and GLP-1 sales, alongside institutional investor support. This points to sustained demand for the company’s distribution business. Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs
• Positive Sentiment: McKesson reportedly raised its fiscal 2027 adjusted EPS outlook, a potential signal of confidence in future earnings. The article listing does not provide the revised forecast figures. McKesson stock raises fiscal 2027 adjusted EPS outlook
• Positive Sentiment: Zacks highlighted McKesson’s growth attributes as reasons investors may find the stock attractive. 3 Reasons Why Growth Investors Shouldn’t Overlook McKesson

McKesson Price Performance

Shares of NYSE MCK opened at $1,080.76 on Thursday. The stock has a market capitalization of $124.79 billion, a P/E ratio of 27.79, a price-to-earnings-growth ratio of 1.83 and a beta of 0.27. McKesson Corporation has a 1-year low of $723.68 and a 1-year high of $1,121.50. The business has a fifty day moving average price of $948.83 and a 200 day moving average price of $871.94.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The company had revenue of $110.96 billion for the quarter, compared to the consensus estimate of $109.90 billion. During the same quarter last year, the company earned $9.86 earnings per share. The firm’s revenue for the quarter was up 7.5% compared to the same quarter last year. As a group, equities research analysts anticipate that McKesson Corporation will post 46.16 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s dividend payout ratio is presently 9.67%.

Insider Activity

In other news, EVP Francisco Fraga sold 650 shares of the firm’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the sale, the executive vice president directly owned 4,414 shares in the company, valued at approximately $4,868,465.44. This trade represents a 12.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the sale, the chief accounting officer owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 2,161 shares of company stock valued at $2,242,515. Insiders own 0.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on MCK shares. JPMorgan Chase & Co. boosted their price target on shares of McKesson from $1,042.00 to $1,255.00 and gave the company an “overweight” rating in a report on Tuesday. Leerink Partners increased their price objective on shares of McKesson from $1,070.00 to $1,200.00 and gave the company an “outperform” rating in a research note on Thursday, November 5th. Mizuho increased their price objective on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research note on Tuesday, October 20th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. Finally, UBS Group boosted their price objective on shares of McKesson from $1,200.00 to $1,250.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and an average price target of $1,040.29.

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.